Streetbeat News

Stock Prices

MRK

MRNA

William Blair initiated coverage on Moderna Inc (MRNA) with a Market Perform rating, establishing a fair value estimate of $136.28 per share. The valuation considers the declining COVID-19 base business, the competitive ex-COVID vaccine landscape, and the timing gap to the early-stage therapeutic pipeline. The firm models around $6.3 billion in global COVID-19 vaccine revenue in 2023. Moderna's personalized cancer vaccine (PCV), developed in partnership with Merck & Co Inc (MRK), has shown positive results in Phase 2 trials and is advancing to Phase 3.

Portfolio Pulse from Vandana Singh

July 24, 2023 | 3:39 pm

HOPE

Hope Bancorp, Inc. reported Q2 revenues of $147.70 million, a 4.3% decline YoY, but beating the consensus of $141.07 million. The company also reported a 4% YoY growth in deposits, reaching $15.62 billion. Despite the revenue decline, HOPE shares are trading higher by 5.45%.

Portfolio Pulse from Nabaparna Bhattacharya

July 24, 2023 | 3:37 pm

ADBE

A significant investor has taken a bullish stance on Adobe (NASDAQ:ADBE), with 50% of investors opening trades with bullish expectations and 50% with bearish. Of the total trades, 8 are puts amounting to $645,330 and 6 are calls amounting to $296,309. The targeted price range for Adobe over the last 3 months is from $430.0 to $630.0. The current price of ADBE is up 0.42% at $522.41, with RSI indicators suggesting it may be approaching overbought. Next earnings are expected in 52 days.

Portfolio Pulse from Benzinga Insights

July 24, 2023 | 3:30 pm

ASML

A significant bearish stance has been taken on ASML Holding (NASDAQ:ASML) as indicated by unusual options activity. The overall sentiment of these big-money traders is split between 43% bullish and 56% bearish. Whales have been targeting a price range from $600.0 to $780.0 for ASML Holding over the last 3 months. Wells Fargo maintains an Overweight rating on ASML Holding with a price target of $800.

Portfolio Pulse from Benzinga Insights

July 24, 2023 | 3:30 pm

LLY

Eli Lilly (NYSE:LLY) has outperformed the market over the past 20 years, producing an average annual return of 10.23%. If an investor had bought $1000 of LLY stock 20 years ago, it would be worth $6,945.15 today. The company currently has a market capitalization of $438.75 billion.

Portfolio Pulse from Benzinga Insights

July 24, 2023 | 3:30 pm

APD

Air Products & Chemicals (NYSE:APD) has outperformed the market over the past 10 years by 1.48% on an annualized basis, producing an average annual return of 11.91%. If an investor had bought $1000 of APD stock 10 years ago, it would be worth $3,108.33 today.

Portfolio Pulse from Benzinga Insights

July 24, 2023 | 3:30 pm

GRPN

Groupon (GRPN) has seen a significant option alert for January 19th $9 calls. A total of 3500 contracts were bought at the ask price of $1.72, compared to an open interest of 5. The company is expected to announce its earnings on August 7th after the market closes. The reference price is $6.57.

Portfolio Pulse from Charles Gross

July 24, 2023 | 3:21 pm

JD

PDD

Shares of several Chinese companies, including JD and PDD, are trading higher after China announced plans to optimize the business environment for private enterprises. This announcement comes ahead of the Politburo meeting later this week.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 3:20 pm

BABA

Alibaba's shares are trading higher following China's announcement to optimize the business environment for private enterprises. Additionally, Alibaba will not participate in Ant Group's share repurchase program.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 3:19 pm

IMAX

IMAX CEO Richard Gelfond discussed Oppenheimer and box office trends on CNBC. No specific details about the discussion were provided.

Portfolio Pulse from Happy Mohamed

July 24, 2023 | 3:19 pm